US Mayo Clinic strikes Irish medtech R&D deal at IN3 2014
This article was originally published in Clinica
Up to ten Irish medtech spinout companies could result from an agreement between the Mayo Clinic and the Irish business and R&D promotion agency Enterprise Ireland (EI), which was signed last week in Dublin, Ireland.
You may also be interested in...
The UK has added important new capabilities to its COVID-19 monitoring and control effort and those running it promise a “world class system” by late summer.
The evolution of how and where patients receive their care has received an unexpected boost from the COVID-19 crisis. Coronavirus volume testing challenges persist, but the global medtech industry is now looking beyond the crisis toward a return to “normal” business.
The advent of COVID-19 and its effects on care delivery have meant that short-term priorities for health care systems have switched temporarily to public health emergency mode. But the longer-term need to restructure delivery around outcomes and federated data management for patients is here to stay, says Royal Philips’ Jeroen Tas.